Interferons: therapeutic prospects.
D000818:Animals; D001102:Arbovirus Infections / Q000188:drug therapy; D004660:Encephalitis / Q000188:drug therapy; D005622:Friend murine leukemia virus; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D007369:Interferon Inducers; D007372:Interferons / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D011063:Poly A-U / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012672:Semliki forest virus; D012845:Sindbis Virus; D014615:Vaccinia / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy*
D007369:Interferon Inducers; D011134:Polysaccharides; D011063:Poly A-U; D007372:Interferons; D011070:Poly I-C